About SCI-B-VAC:

Hepatitis B virus (HBV) causes an incurable and sometimes fatal liver disease striking several hundred thousand new victims every year all over the world. According to a recent World Health Organization estimate, approximately 2 billion of the 5.4 billion people of the world population have been infected with HBV.

Sci-B-Vac™ is a recombinant Hepatitis B vaccine, produced by Scigen Israel Ltd. It is produced in mammalian Chinese hamster ovary (CHO) cells, comprising the three HBV envelope proteins SHBs-S, MHBs-pre-S2, and LHBs-pre-S1. The Sci-B-Vac™ active component is highly similar to the wild type viral envelope, more potent and immunogenic than other existing yeast derived HB vaccines.

Video Gallery

THIS WEBSITE IS NOT INTENDED FOR USA OR CANADIAN CITIZENS. Content is provided for informational purposes only. This website cannot substitute the advice of your own physician or other medical professionals. Do not use the information in this site for diagnosing or treating a health problem. Content of this website is written by a third party, Onconsult Ltd, has no responsibility for content displayed in this site, for it's correctness and reliability. (c) OnConsult 2014